Publikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (Spain) (26)

2021

  1. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)

    Drugs

  2. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    Drugs, Vol. 81, Núm. 15, pp. 1763-1774

2020

  1. Management of adult patients with PAH in Spain: current practice, resources, and needs (AIRE17 Study)

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 147-154

2013

  1. Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain

    Expert Opinion on Drug Safety, Vol. 12, Núm. 4, pp. 455-463

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

2009

  1. Prevalence of HLA-B*5701 in HIV-infected patients in spain (results of the epi study)

    HIV Clinical Trials, Vol. 10, Núm. 1, pp. 48-51

2008

  1. Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Núm. 8, pp. 679-683

  2. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313

  3. β-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: An in vitro pharmacodynamic simulation

    Chemotherapy, Vol. 54, Núm. 2, pp. 84-90

2007

  1. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: Recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 7, pp. 2564-2573

  2. Levofloxacin vs. azithromycin pharmacodynamic activity against S. pneumoniae and H. influenzae with decreased susceptibility to amoxicillin/clavulanic acid

    Journal of Chemotherapy, Vol. 19, Núm. 6, pp. 670-672

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

  2. Situación de la cefalosporina oral de tercera generación cefditoreno pivoxil en el tratamiento de la infección comunitaria del adulto

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 3, pp. 210-216

2004

  1. Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients

    HIV Clinical Trials, Vol. 5, Núm. 1, pp. 33-39

  2. Effects of effervescent ranitidine on gastric pH: Comparison with almagate and placebo in fasting and postprandial conditions

    Alimentary Pharmacology and Therapeutics, Vol. 20, Núm. 6, pp. 683-688

  3. In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin

    International Journal of Antimicrobial Agents, Vol. 24, Núm. 1, pp. 79-82

  4. Resistencias bacterianas y farmacodinámica como bases de la prescripción de antibióticos en infecciones respiratorias

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 4, pp. 230-237

2003

  1. Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination

    Infection, Vol. 31, Núm. 1, pp. 51-54

  2. Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility

    Journal of Clinical Microbiology, Vol. 41, Núm. 6, pp. 2385-2390

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667